Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Background The SPACE trial is a multinational, prospective, randomised study to test the
hypothesis that carotid artery stenting is not inferior to carotid endarterectomy for treating …

Background Many patients with stroke are precluded from thrombolysis treatment because
the time from onset of their symptoms is unknown. We aimed to test whether a mismatch in …

The original version of this consensus statement on mechanical thrombectomy was approved
at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference in …

Background and Purpose— There has been speculation that the risk of secondary symptomatic
intracranial hemorrhage (SICH) may be increased after thrombolytic therapy in ischemic …

Background Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are used to
prevent ischaemic stroke in patients with stenosis of the internal carotid artery. Better …

Background Mechanical thrombectomy (MT) has become the cornerstone of acute ischemic
stroke management in patients with large vessel occlusion (LVO). Objective To assist …

Objective o evaluate the use of fluid‐attenuated inversion recovery (FLAIR) imaging as
surrogate marker of lesion age within the first 6 hours of ischemic stroke. Methods e analyzed …

Background and Purpose— The use of intravenous thrombolysis is restricted to a minority of
patients by the rigid 3-hour time window. This window may be extended by using modern …

Background and Purpose— A mismatch between diffusion- and perfusion-weighted MRI is
thought to define tissue at risk of infarction. This concept is based on the assumption that …